Uncertain Outlook for Pharma and Biotech Deals Following ‘Turbulent 2011’ (Young & Partners Article in Pharmaceutical Executive April 18, 2012)

Assessment of the M&A, Equity and Debt Financing and Stock Market in 2011 and what lies ahead

ATT00022